WilmerHale Reps Eko Devices in $5M Series A Round Led by ARTIS Ventures
On February 28, 2018, Eko Devices, a leader in acoustic cardiac , announced that it closed $5 million in Series A funding to grow its commercial team and to expand clinical studies on the use of its platform for valvular heart disease screening and heart failure . ARTIS Ventures led the round, with additional from Strategic Partners, DreamIt Ventures, 1812 Ventures, and FOUNDER.org.
WilmerHale's Joe Wyatt and Molly Holsinger represented Eko Devices in this transaction.
View Eko's full release about this announcement.